Encompass Health

Q2 FY2026 EarningsQ2 FY26 results beat consensus across all major financial metrics, with revenue reaching $1,597.4M (+1.66% vs. $1,571.3M expected) and GAAP EPS of $1.55 (+5.95% vs. $1.46 expected). Growth was primarily driven by a 5.6% increase in discharges and a 3.9% improvement in net patient revenue per discharge. Management signaled continued confidence by increasing the quarterly dividend to $0.21 and resetting the share repurchase authorization to $1.0B.